Cancer | Screening methods | Verification methods | Candidate biomarkers | References |
---|---|---|---|---|
Lung | SDS-PAGE/nano-ESI-MS/MS | ELISA | CD98, fascin, 14-3-3 η, polymeric immunoglobulin receptor/secretory component | [73] |
 | 2-DE/MALDI-TOF/TOF-MS | Western blot/ELISA/IHC | Cathepsin D | [28] |
 | 2-DE/MALDI-TOF-MS | RT-PCR/western blot/ELISA/IHC | Dihydrodiol dehydrogenase | [27] |
 | SDS-PAGE/MALDI-TOF-MS | ELISA | L-lactate dehydrogenase B | [90] |
 | 2-DE/MALDI-TOF-MS | RT-PCR/enzyme activity detection | Mn-SOD | [29] |
Liver | LC-MS/MS | Western blot | Apolipoprotein E, DJ-1, apolipoprotein H, galectin-3, cathepsin L, cyclophilin A, cystatin C | [41] |
Pancreatic | NuPAGE/LC-MS/MS/SILAC | Western blot/IHC | CD9, perlecan, SDF4, apolipoprotein E, fibronectin receptor, Mac-2 binding protein, cathepsin D, cathepsin B, MCP-1, L1CAM | [25] |
 | LC-MS/MS | RT-PCR/western blot/IHC | CSPG2/versican, Mac25/angiomodulin | [43] |
Bladder | SDS-PAGE/MALDI-TOF-MS | Western blot | Pro-u-plasminogen activator | [91] |
 | LC-MS/MS |  | CXCL1 | [92] |
Nasopharyngeal | SDS-PAGE/MALDI-TOF-MS | Western blot/ELISA/IHC | Fibronectin, Mac-2 binding protein, plasminogen activator inhibitor 1 | [69] |
Prostate | LC-MS/MS | Western blot/ELISA | Mac-2 binding protein | [40] |
 | Oligonucleotide microarray/genome-based computational prediction | RT-PCR/ELISA/IHC | Macrophage inhibitory cytokine 1 | [22] |
 | LC-MS/MS | ELISA | follistatin, chemokine (C-X-C motif) ligand 16, pentraxin 3, spondin 2 | [93] |
Melanoma | NuPAGE/LC-Q-TOF-MS/MS | Western blot | Cathepsin D, gp100 | [79] |
Breast | LC-MS/MS | Western blot | Galectin-3-binding protein, alpha-1-antichymotrypsin | [94] |
 | LC-MS/MS | ELISA | Elafin | [95] |
Colorectal | SDS-PAGE/MALDI-TOF-MS | Q-PCR/Western blot/IHC/ELISA | Collapsing response mediator protein-2 | [72] |
 | 2-DE/DIGE/MALDI-TOF-MS | Northern blot/western blot | Cathepsin D, stratifin, calumenin | [21] |
Renal | 2-DE/MALDI-TOF-MS/immunoblotting | Western blot/homogeneous fluorescent immunoassay | Pro-MMP-7 | [68] |
Oral | SDS-PAGE/MALDI-TOF-MS | Western blot/IHC/ELISA | Mac-2 binding protein | [70] |
Fibrosarcoma | Capillary ultrafiltration probe/2-DE/MALDI-TOF-MS |  | Cyclophilin A, S100A4, profiling-1, thymosin beta 4, thymosin beta 10, fetuin-A, alpha-1 antitrypsin 1–6, contrapsin, apolipoprotein A-1, apolipoprotein C-1 | [31] |
Ovarian | SELDI-TOF MS | Immunodepletion | CXC chemokine ligand 1, intact and truncated interleukin 8 | [66] |
 | HPLC fractionation/LC-MS/MS | Immunoblot/immunofluorescence | 14-3-3 zeta | [96] |